Title and duration

Funding agency

Dr. S. K. Jindal

•  Assessment of RNTCP strategy of FNAC diagnosis (at 2 weeks) and 6 month duration of treatment for peripheral tubercular lymphadenitis (2007-2009)

Central TB Division, DGHS

•  Indian multicentric study on epidemiology of asthma and chronic bronchitis in adults (INSEARCH)

Indian Council of Medical Research

•  HIV infection, alcohol and pleuro-pulmonary tuberculosis: a study on cellular homeostasis (2005-08)

NIH, USA

•  Formulation of Training Modules for management of asthma and COPD at primary level of health care in India (2006-07)

WHO-India

•  Development of National Guidelines for management of asthma in India (2005-06)

WHO-India

•  Global Youth Tobacco Survey (for Jammu and Kashmir ) (2004-05)

CDC-WHO

•  Multicentric study on prevalence of bronchial asthma ( 2002-04)

Indian Council of Medical Research

•  Global Youth Tobacco Survey (for Punjab, Haryana, Himachal Pradesh, and Chandigarh ) (2003-04)

CDC-WHO

Dr. Dheeraj Gupta

•  Mechanisms involved in down regulation of effector T cell-activity in tuberculosis and HIV co-infection (2007-09)

Department of Biotechnology

•  Study on population prevalence of pulmonary tuberculosis in district SAS Nagar (2008-09)

Central TB Division, DGHS, Delhi

Dr. Ashutosh N. Aggarwal

•  Assessment of health related quality of life in patients with lung cancer using generic and disease specific questionnaires (2009-11)

Indian Council of Medical Research

•  Utility of generic and disease-specific health related quality of life instruments as outcome measures for tuberculosis patients treated under Revised National Tuberculosis Control Programme at Chandigarh (2006-08)

Central TB Division, DGHS, Delhi

B. Industry sponsored clinical trials

•  A study of Mycobacterium W in combination with Paclitaxel plus Cisplatin in advanced non-small cell lung cancer (ongoing)

Cadila Pharmaceuticals

•  Inhaled preprandial human insulin with AERx â iDMS versus subcutaneous injected insulin aspart in subjects with diabetes and asthma: a 52-week, open-label, multinational, randomised, parallel trial for long-term safety (2007-08)

Novo Nordisk India

•  Inhaled pre-prandial human insulin with AERx â iDMS versus subcutaneous injected insulin aspart in subjects with diabetes and chronic obstructive pulmonary disease: a 52-week, open-label, multinational, randomised, parallel trial for long-term safety (2007-08)

Novo Nordisk India

•  Randomized double blind clinical trial of ceftobiprole vs. ceftazidime plus linezolid in treatment of nosocomial pneumonia (2007)

Johnson and Johnson

•  Randomized, open-label, Phase III trial of Paclitaxel / Carboplatin plus PF-3512676 vs. Paclitaxel / Carboplatin as first line treatment of patients with advanced non-small cell lung cancer (2007-08)

Pfizer

•  Randomized double blind clinical trial of HFA budesonide and formoterol inhaler with CFC budesonide and formoterol inhalers in stable asthma (2005)

Cipla